Dr. Reddy's Files FDA ANDA For UCB Epilepsy Drug

Law360 (March 22, 2004, 12:00 AM EST) -- Indian drug maker Dr. Reddy's Laboratories has filed an abbreviated new drug application with the United States Food and Drug Administration for levetiracetam, a generic form of Belgian pharmaceutical company UCB's epilepsy drug Keppra.

UCB has already filed a law suit against Dr.Reddy's in the U.S. district court for the District of Georgia, alleging patent infringement on the two Orange Book patents.

Dr. Reddy’s said it had made a Paragraph IV filing on the two patents in the so-called "Orange Book", which lists multiple patents on...
To view the full article, register now.
Law360 Pro Say Podcast
Check out Law360's new podcast, Pro Say, which offers a weekly recap of both the biggest stories and hidden gems from the world of law.